SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Age-Related Macular Degeneration Pipeline Highlights - 2014

[December 23, 2013]

Research and Markets: Global Age-Related Macular Degeneration Pipeline Highlights - 2014

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/r4ntmv/global) has announced the addition of the "Global Age-Related Macular Degeneration Pipeline Highlights - 2014" report to their offering.

The latest report Age-Related Macular Degeneration Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global age-related macular degeneration market. It covers emerging therapies for age-related macular degeneration in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides age-related macular degeneration pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trils, preclinical research, and discovery stage.


Drug Mechanism Classes:

The report provides age-related macular degeneration pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides age-related macular degeneration pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which age-related macular degeneration pipeline products will be launched in the US and Ex-US till 2017.

SUMMARY:

- Age-Related Macular Degeneration phase 3 clinical trial pipeline molecules

- Age-Related Macular Degeneration phase 2 clinical trial pipeline molecules

- Age-Related Macular Degeneration phase 1 clinical trial pipeline molecules

- Age-Related Macular Degeneration preclinical research pipeline molecules

- Age-Related Macular Degeneration discovery stage pipeline molecules

- Age-Related Macular Degeneration pipeline molecules short-term launch highlights

Key Topics Covered:

1. Age-Related Macular Degeneration Pipeline by Stages

2. Age-Related Macular Degeneration Pipeline by Drug Class

3. Age-Related Macular Degeneration Pipeline by Company

4. Age-Related Macular Degeneration Phase 3 Clinical Trial Insights

5. Age-Related Macular Degeneration Phase 2 Clinical Trial Insights

6. Age-Related Macular Degeneration Phase 1 Clinical Trial Insights

7. Age-Related Macular Degeneration Preclinical Research Insights

8. Age-Related Macular Degeneration Discovery Stage Insights

9. Appendix

10. Research Methodology

Tables

Figures

For more information visit http://www.researchandmarkets.com/research/r4ntmv/global

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.